From the No. 1 Scholar in the College Entrance Examination to the Overlord of Science and Technology

Chapter 61

Tianfang Pharmaceutical’s original main drug product belongs to cell pharmaceuticals.

Therefore, the equipment required for cell pharmacy is readily available.

The anti-cancer drugs that Jiang Cheng wants to develop are not difficult for Jiang Cheng. In essence, they can also be regarded as a cellular pharmaceutical process.

The traditional cell pharmacy process is to use the cell as a unit, apply cell biology, molecular biology and other theories and technologies, purposefully design and carefully operate, so that certain genetic characteristics of the cell will be changed to improve or produce new The purpose of the variety, and to increase or regain the ability of cells to produce a certain product, so that they can be cultured and proliferated in a large amount under in vitro conditions, and products useful to humans can be extracted.

Humans can use materials derived from animal and plant cells to make medicines.

However, the process of anti-cancer drugs made by Jiang Cheng is several grades higher than that of traditional cellular pharmaceuticals.

In fact, in real life, there are many things that can effectively prevent and kill cancer cells, but why the anti-cancer drugs have not made substantial progress.

The treatment of cancer can still only rely on chemotherapy to reluctantly cure. The main reason is that humans still do not have the ability to completely integrate these things that can kill 140 cells of cancer cells and use them.

Whether it is to take out the desired cells from animals or plants, if some technologies cannot be achieved, it will destroy the structure of the cells and damage their characteristics. In addition, the technology of fusion transformation is immature.

Therefore, even if the required medium is finally extracted, there is still no way to effectively apply it to the clinic.

These technologies have not yet been fully mastered by humans.

Inside the laboratory on the second floor.

Jiang Cheng debugged all the equipment and they were all good and ready for use.

On the laboratory table, the pharmaceutical raw materials purchased by Jiang Cheng include bitter gourd, kiwi fruit, wheat bran, radish, and kelp.

It can be said that they are all very common ingredients and fruits, which are far behind the noble things like anti-cancer drugs.

However, people who are engaged in relevant medical professions actually understand that most of the medicines they come into contact with in the clinic come from very ordinary ones, and they are all basic animals and plants.

It’s just that the substances extracted from animals and plants are finally transformed into medicines. This process is a technical process.

The five raw materials of bitter gourd, kiwi, wheat bran, radish, and kelp contain anti-cancer substances that Jiang Cheng needs.

The anti-cancer effect of bitter gourd comes from a quinine-like protein, which is an active protein that can activate immune cells. The immune cells act as a “second setter” to kill cancer cells or other abnormal cells.

Kiwi: The vitamin C content ranks first among fruits.

Wheat bran: the best anti-cancer dietary fiber, can prevent and treat colorectal cancer, diabetes and hypercholesterolemia, hyperlipidemia, constipation, hemorrhoids, etc.

Radish contains a variety of enzymes, which can eliminate the carcinogenic effects of nitrosamines. The essential element can stimulate the body’s immunity, increase the activity of macrophages, and enhance its ability to swallow and kill cancer cells.

The traditional Chinese medicine of kelp is called “Kombu”, which can prevent breast cancer and thyroid tumors.

Cancer cells are a type of cell in the human body. Everyone has proto-oncogenes and tumor suppressor genes, but not everyone has cancer cells in their bodies. Proto-oncogenes are responsible for the cycle of cell division and proliferation, and human growth needs it.

But when it mutates, it will give rise to cancer cells.

The mechanism of anti-cancer drugs studied by Jiang Cheng is one of effective prevention, and the other is to kill cancer cells as soon as they appear.

Taking advantage of these anti-cancer raw materials, which have specific mechanisms for cancer cells, after humans take the anti-cancer drugs he developed, they can promote the generation of a new type of anti-cancer target cell in the body. Guards who monitor cancer cells.

Once cancer cells appear in the human body, they are killed immediately without side effects.

Such an effective anti-cancer drug is definitely what everyone dreams of, but it has not been developed because of insufficient technology.

But this is not difficult for Jiang Cheng.

Soon, Jiang Cheng buried his head in the research room, using the biotechnology he mastered to start the production of anti-cancer drugs.

The instruments and equipment in the laboratory started to operate.

Jiang Cheng’s figure walked back and forth in it alone, constantly busy.

As time passed, Jiang Cheng was completely immersed in the drug development process. He mastered the pharmaceutical technology, but he still needed to make the first batch of experimental drugs himself.

Then conduct trials, non-Linchuan trials and clinical trials, and finally get approval from the State Drug Administration.

Of course, it only takes a little time for Jiang Cheng now.

eight pm!

Phoo~

Jiang Cheng sighed for a long time, looked at the brown potion in the reagent tube, smiled on his face, and finally finished.

The brown medicine in this test tube is an anti-cancer drug developed by Jiang Cheng, and it can be administered directly by intravenous infusion.

“Before the clinical trial, several non-clinical trials are needed,” Jiang Cheng said secretly.

The first non-clinical test is to test whether the anti-cancer drug is effective on cancer cells, and the second is to test whether the drug has side effects when used in humans.

If there is a problem with one of the two, then the anti-cancer drug is equivalent to a failure.

Moreover, after all non-clinical trials are qualified, Jiang Cheng also needs to apply to the National Food and Drug Administration for clinical trials of anti-cancer drugs. After all the non-clinical trials are qualified, the drugs can be mass-produced and put into use.

According to the current national drug control policy, it can be said that this series of things is not simple.

But it’s different for Jiang Cheng, who makes him relevant!

He is not in vain as the special consultant of the Institute of Biology of the Chinese Academy of Sciences.

He has already thought about how to publish his anti-cancer drugs in a reasonable and effective manner.

ps: The seventh watch, ask for automatic subscription, ask for the fix, there are still three changes, but it will definitely not only update the third watch, it will be updated all the time, just ask the brothers to subscribe to be able to work hard, and seek completeness. .